HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Some studies do not list a clear city. Always confirm the location with the study team.

Some visits may still be in person. Participation depends on the study’s location and eligibility requirements.

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 505-516 of 4,505
Other study type icon
Not Yet RecruitingACTRN12618000377235

Feasibility of a prototype for Individual Placement and Support (IPS) - Waitemata District Health Board (DHB)

Official study title

Feasibility of an Individual Placement and Support (IPS) prototype developed by Waitemata District Health Board (DHB) for people aged 18-35 with severe mental health conditions

This study isn't recruiting yet.

In New Zealand
Schizophrenia, BipolarityInterventional studyAges 18–35
Countries
New Zealand
Sponsor
Ministry of Social Development
Other study type icon
RecruitingNCT05880719

Computer-assisted music cognitive training after a first episode of psychosis

About this title

Pilot and Descriptive Study of the Effects of Setting up Computer-assisted Music (CAM) Remediation Groups on the Cognitive Functioning of Young Patients With a First Episode Psychosis (PEP)

Read the official source — NCT05880719
Official study title

Pilot and Descriptive Study of the Effects of the Implementation of Computer Assisted Music Remediation Groups on the Cognitive Functioning of Young Patients Presenting a First Episode Psychosis

In Caen
SchizophreniaInterventional studyAges 18–30
Countries
France
Sponsor
University Hospital, Caen
Other study type icon
Not Yet RecruitingNCT07102784

Adapting a Socio-cognitive Intervention to Early Psychosis Services

Official study title

Adapting the Social Cognition and Interaction Training (SCIT) for Early Intervention Psychosis. A Preliminary Qualitative Study.

This study isn't recruiting yet.

Location not clearly listed
SchizophreniaObservational studyAges 18+
Countries
Sponsor
King's College London (University)
Drug study icon
CompletedNCT03568500

A study to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic

Official study title

A Multicentre, 8-week, Single-arm, Open-label, Pragmatic Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adult Subjects With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic (Aripiprazole, Olanzapine, Quetiapine, or Risperidone)

This study has finished and is no longer accepting participants.

Multiple locations, including Chertsey
SchizophreniaMedication studyAges 18–65
Countries
United Kingdom
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.